Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ARA Avanti Rx Analytics

ARA Avanti Rx Analytics?uq=U5Zpp9ZJ
M&A STATUS
Corporate LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

developer and producer of pharmaceutical products. The company's pharmaceutical products includes marijuana and cannabis infused-products which are made through analytical research and development, testing, cannabis purification and formulation, enabling its patients to improve the quality of life avail by quality control, quality assurance, scientific research, and extraction.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • 135 Devon Road
  • Unit 11
  • Brampton, Ontario L6T 5A4
  • Canada

+1 (416) 000-0000

ARA Avanti Rx Analytics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore ARA Avanti Rx Analytics‘s full profile, request access.

Request full access to PitchBook

ARA Avanti Rx Analytics Executive Team (1)

Name Title Board
Seat
Contact
Info
Mehrdad Barghian Ph.D President & Chief Executive Officer